Many people who use methamphetamine will not develop psychosis, but a significant minority do experience paranoid thoughts, hallucinations, or other serious psychiatric symptoms that require medical care. This page explains common symptoms, immediate safety steps, how clinicians decide between outpatient and more intensive care, and evidence-based treatment approaches. This information is educational only and not a substitute for a medical assessment.

What is methamphetamine psychosis?

Methamphetamine psychosis is a set of symptoms that can occur during or after use of methamphetamine. Symptoms may include paranoid thoughts, hearing or seeing things that others do not, extreme agitation, or disorganized thinking. These symptoms can look like primary psychotic disorders such as schizophrenia, but they are related to stimulant exposure and brain effects of the drug. Public health agencies note methamphetamine can cause serious mental and physical harms including psychosis, cardiovascular injury, and insomnia. Centers for Disease Control and Prevention: Stimulants and health effects. (cdc.gov)

How common and how serious is it?

Not everyone who uses methamphetamine develops psychosis, but studies show higher rates of psychotic symptoms among people with methamphetamine use disorder. Some people recover fully after stopping the drug, while others may have persistent or recurrent psychosis that leads to a long term psychiatric diagnosis. A systematic review found that about one in five people with stimulant induced psychosis later received a diagnosis of schizophrenia or a related disorder, depending on the study and follow-up time. Systematic review on transition from substance induced psychosis. (pmc.ncbi.nlm.nih.gov)

Typical symptoms to watch for

  • Paranoia, strong fears that people are trying to harm you
  • Auditory hallucinations, such as hearing voices, or less commonly visual hallucinations
  • Severe agitation, aggression, or unpredictable behavior
  • Disordered or rapidly changing thoughts, trouble organizing speech
  • Insomnia, extreme anxiety, or mood disturbances
  • Physical signs suggesting medical danger: very fast heartbeat, chest pain, trouble breathing, high body temperature, fainting, or seizures

Any of the above with self harm, suicidal thoughts, or inability to care for basic needs requires urgent professional evaluation. Guidance for front line clinicians emphasizes a medical evaluation to identify life threatening causes before psychiatric treatment. Management of withdrawal and detoxification evidence review. (ncbi.nlm.nih.gov)

Immediate safety steps

  • If someone is in immediate danger to themselves or others, call 911 right away.
  • For a mental health or suicide crisis, call or text 988 for the United States Suicide and Crisis Lifeline.
  • If the person is physically ill, extremely agitated, or having seizures, go to the nearest emergency department for medical stabilization.
  • Keep the person calm, in a low stimulation environment, and remove objects that could be used to cause harm.
  • Provide clear information to first responders or clinicians about recent substance use, other medications, medical history, and any prior psychiatric diagnoses.
Care setting When it is used Who it is for Pros Cons
Emergency department Severe agitation, medical instability, high fever, seizures, inability to stay safe People needing immediate medical stabilization Rapid medical workup and stabilization, access to IV meds and monitoring Can be disruptive, may require admission
Inpatient psychiatric unit or medically supervised detox Persistent psychosis, risk of harm, severe withdrawal, co-occurring medical problems Those who need continuous observation, medication initiation, or 24 hour care Safe, structured environment with regular nursing and psychiatric care Shorter length of stay, requires referral and bed availability
Outpatient treatment and follow up Mild or resolving symptoms, clinically stable, good social supports People safe at home who can attend frequent visits Lower cost, maintain daily life, access to counseling and medications Requires reliable engagement and quick access if symptoms worsen

Medical treatment options

Acute management focuses on safety, treating severe agitation, and reducing psychotic symptoms while clinicians rule out medical causes. Evidence and clinical guidance recommend fast medical assessment and use of sedating medications when needed, typically benzodiazepines and antipsychotics, depending on the clinical picture. Clinicians should monitor heart rate, blood pressure, body temperature, and breathing while treating stimulant related agitation or psychosis. ASAM/AAAP Clinical Practice Guideline on Management of Stimulant Use Disorder. (pmc.ncbi.nlm.nih.gov)

Systematic reviews show antipsychotic medications can reduce hallucinations and delusions in stimulant induced psychosis during the acute phase, and benzodiazepines are frequently used for severe agitation. Decisions about which medication to use depend on the person linical history, potential side effects, pregnancy status, and other medical conditions. Clinicians should review risks and benefits and monitor for medication adverse effects. Review of methamphetamine induced psychosis and treatment. (pmc.ncbi.nlm.nih.gov)

What about continuing antipsychotic medication long term?

Some people recover when the drug is stopped and short term medication helps symptoms resolve. Others have repeated episodes or persistent psychotic illness requiring ongoing psychiatric care. Best practice is individualized assessment, regular review of the need for ongoing antipsychotic medication, and collaboration between addiction and psychiatric teams. A network of clinical reviews and guideline documents urge clinicians to reassess the indication for long term antipsychotic treatment regularly. Systematic review of antipsychotics for amphetamine psychosis. (pmc.ncbi.nlm.nih.gov)

Ongoing addiction treatment

Treating the underlying stimulant use disorder reduces the risk of recurrent psychosis. There are no federally approved medications specifically for methamphetamine addiction in general use, but structured psychosocial treatments have the best evidence. Contingency management, especially when combined with community reinforcement approaches, shows the largest and most consistent effect on reducing stimulant use in randomized trials and meta-analyses. Network meta-analysis of psychosocial interventions. (pmc.ncbi.nlm.nih.gov)

SAMHSA and treatment reviews recommend integrating behavioral therapies, relapse prevention, and linkages to social supports, with careful attention to coexisting mental health conditions. Many effective programs combine medication management for psychiatric symptoms with psychosocial treatment for addiction. SAMHSA TIP 33, Treatment for Stimulant Use Disorders. (govinfo.gov)

Special situations

Pregnancy, adolescence, severe medical problems, or co-occurring seizure disorders require specialized care. Pregnant people should be evaluated by clinicians experienced in both addiction medicine and prenatal care before starting medications that could affect the fetus. Adolescents and people with history of severe psychiatric illness may need multi disciplinary care or inpatient services. If you are uncertain, seek urgent evaluation at an emergency department or call your local crisis line. NIDA: Methamphetamine research and clinical resources. (irp.cdn-website.com)

Frequently asked questions

Will the psychosis go away if the person stops using methamphetamine?

Many people improve after stopping methamphetamine and receiving short term medical treatment, but some people have persistent symptoms or repeated episodes. Ongoing follow up with psychiatry and addiction treatment is important to reduce risk of recurrence. Meta analysis on outcomes of substance induced psychosis. (pmc.ncbi.nlm.nih.gov)

Can antipsychotic medications make stimulant related problems worse?

Antipsychotics can have side effects, and certain medications require monitoring. Clinical guidelines support using antipsychotics when psychosis or dangerous agitation is present, while continually reassessing the need for continued medication. Medical teams balance benefits and risks for each patient. ASAM/AAAP guideline. (pmc.ncbi.nlm.nih.gov)

Are there medications that treat methamphetamine addiction itself?

No specific medication has broad regulatory approval as a standalone treatment for methamphetamine use disorder across all populations. Research continues, and many programs use psychosocial treatments with the best evidence, such as contingency management plus community reinforcement. Psychosocial treatment meta analysis. (pmc.ncbi.nlm.nih.gov)

Sources and further reading

Next steps and how we can help

If you or a loved one are experiencing psychotic symptoms after using methamphetamine, seek urgent care if there is any danger, severe agitation, medical symptoms, or risk of self harm. For non emergent help in New Jersey, ReachNJ provides 24 7 assistance and referrals to local treatment resources. ReachNJ. (nj.gov)

For outpatient evaluation and coordinated care, a qualified clinician must assess medical stability, psychiatric history, and risk factors before recommending medication or a particular level of care. Our team can help arrange a confidential assessment, explain treatment options, and connect you with counseling and evidence based programs. For information on services and treatments we offer, see our treatments page at Treatment options, find a location at Locations, or reach out via Contact us.

Important safety reminder: if someone is in immediate danger, call 911. For a mental health or suicide crisis, call or text 988.

This page is general education and does not replace a clinical evaluation. Medication and placement decisions should be made by a qualified clinician who has assessed the individual. If you would like help arranging an assessment or learning more about care options, request a confidential assessment or speak with our admissions team today.